Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 134,297 shares, a growth of 664.1% from the July 30th total of 17,575 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 185,827 shares, the short-interest ratio is presently 0.7 days.
Wall Street Analysts Forecast Growth
Separately, Zacks Research cut Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 22nd. Two investment analysts have rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.
Check Out Our Latest Report on SKHHY
Sonic Healthcare Trading Down 4.9%
About Sonic Healthcare
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Further Reading
- Five stocks we like better than Sonic Healthcare
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
